The iClinic™ Precision Health Screening harnesses genomics and epigenetics to provide deep insights into individual health risks and longevity potential. By analysing DNA/RNA profiles and epigenetic markers, we uncover predispositions to conditions like cardiovascular disease, cancers, and neuro-degenerative disorders long before symptoms manifest.
Share:
Patients receive detailed reports on genetic variants affecting metabolic pathways, nutrient metabolism, detoxification, and inflammation, paired with actionable recommendations for diet, exercise, lifestyle management and nutraceutical supplementation. Epigenetic analysis further reveals how lifestyle impacts gene expression, enabling tailored interventions to “turn off” or reduce the effects of harmful pathways. This proactive approach empowers patients with early risk prediction and strategies to optimize health-span. Regular re-screening tracks epigenetic changes, ensuring interventions remain aligned with evolving health needs. By combining innovative science with clinical expertise, The iClinic™ delivers a roadmap to longevity that is both predictive and preventive, setting a new standard in personalized medicine and Lifecare.
Have questions or need another service? Licensed clinicians are just a text away.
